Asset Details
Do you wish to reserve the book?
Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis
Do you wish to request the book?
Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis
2017
Overview
High concentrations of methylglyoxal (MGO) cause cytotoxiticy via formation of advanced glycation endproducts (AGEs) and inflammation. MGO is detoxificated enzymatically by glyoxalase-I (Glo-I). The aim of this study was to analyze the role of Glo-I during the development of cirrhosis.
In primary hepatocytes, hepatic stellate cells (pHSC) and sinusoidal endothelial cells (pLSEC) from rats with early (CCl4 8wk) and advanced cirrhosis (CCl4 12wk) expression and activity of Glo-I were determined and compared to control. LPS stimulation (24h; 100ng/ml) of HSC was conducted in absence or presence of the partial Glo-I inhibitor ethyl pyruvate (EP) and the specific Glo-I inhibitor BrBzGSHCp2. MGO, inflammatory and fibrotic markers were measured by ELISA and Western blot. Additional rats were treated with CCl4 ± EP 40mg/kg b.w. i.p. from wk 8-12 and analyzed with sirius red staining and Western blot.
Expression of Glo-I was significantly reduced in cirrhosis in whole liver and primary liver cells accompanied by elevated levels of MGO. Activity of Glo-I was reduced in cirrhotic pHSC and pLSEC. LPS induced increases of TNF-α, Nrf2, collagen-I, α-SMA, NF-kB and pERK of HSC were blunted by EP and BrBzGSHCp2. Treatment with EP during development of cirrhosis significantly decreased the amount of fibrosis (12wk CCl4: 33.3±7.3%; EP wk 8-12: 20.7±6.2%; p<0.001) as well as levels of α-SMA, TGF-β and NF-κB in vivo.
Our results show the importance of Glo-I as major detoxifying enzyme for MGO in cirrhosis. The reduced expression of Glo-I in cirrhosis demonstrates a possible explanation for increased inflammatory injury and suggests a \"vicious circle\" in liver disease. Blunting of the Glo-I activity decrease the amount of fibrosis in established cirrhosis and constitutes a novel target for antifibrotic therapy.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
Advanced glycosylation end products
/ Animals
/ Collagen
/ Enzyme-linked immunosorbent assay
/ Enzymes
/ Fibrosis
/ Glutathione - analogs & derivatives
/ Inflammation - complications
/ Kinases
/ Lactoylglutathione Lyase - analysis
/ Lactoylglutathione Lyase - antagonists & inhibitors
/ Lactoylglutathione Lyase - immunology
/ Liver
/ Liver Cirrhosis - complications
/ Liver Cirrhosis - drug therapy
/ Liver Cirrhosis - immunology
/ Male
/ Medicine
/ Medicine and Health Sciences
/ Proteins
/ Rats
/ Research and Analysis Methods
/ Rodents
